leadership
confidence high
sentiment negative
materiality 0.65
Traws Pharma President & CSO Oncology resigns; Board disputes severance claim
Traws Pharma, Inc.
- Steven M. Fruchtman resigned as President and Chief Scientific Officer, Oncology, effective June 17, 2024.
- Fruchtman's attorney claims resignation is for 'good reason' under employment agreement, expecting severance related to change in control.
- Board accepted resignation immediately but disagrees with characterization; believes no severance payments are due.
- Victor Moyo continues as Chief Medical Officer, Oncology.